VENUS CONCEPT Venus Viva, Руководство пользователя, Страница: 12 / 53

Venus VIVA User Manual Effective Date: 28.07.13 P/N: DCVIROW3 Rev.01
the plug).
 Do not use the System unless all enclosure panels are properly in place.
 Do not tamper with the controls or attempt to open up the System.
 Do not abuse, sit or lean on the system.
 Venus Viva System should be kept out of the reach of Children.
 Do not allow the Applicators to come in contact with metal elements this
could damage the (MP)
2
electrodes.

A patient history should be completed prior to treatment to ensure no
complications could arise. It is important to verify client does not full
under the exclusion criteria.

The PATIENT should not come into contact with metal parts which are
earthed or which have an appreciable capacitance to earth (for example
operating table supports, etc). The use of antistatic sheeting is
recommended for this purpose.

The cables to the Applicators should be positioned in such a way that
contact with the PATIENT or other leads is avoided.
 The product should not be in contact with other equipment.
 Failure of the System could result in an unintended increase of output
power.
 Interference produced by the operation of HF SURGICAL
EQUIPEMENT may adversely influence the operation of other electronic
EQUIPEMENT.

For PATIENT with cardiac pacemakers or other active implants, a
possible hazard exists because interference with the action of the
pacemakers may occur, or the pacemaker may be damaged. In case of
doubt, approved qualification advice should be obtained.

This equipment/system may cause radio interference or may disrupt the
operation of nearby equipment. It may be necessary to take mitigation
measures. Such as reorienting or relocating.

Portable and mobile RF communications equipment can affect the
System.

The patient should then be fully informed of the treatment protocol,
expected results and should sign informed consent form prior to
beginning treatments.
 Only authorized person is allowed to stand near the system during the
treatment.
 Stop the treatment in case of unexpected changes in client’s condition.
3-2